Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Strategy/Company/Operations Update

2 Dec 2016 11:18

NEW CENTURY AIM VCT 2 PLC

In October 2016, the above fund was approaching its tenth anniversary. With a diverse portfolio of AIM stocks, the company was performing reasonably well and was the second highest performing fund out of 11 funds in the AIM VCT sector over the previous three year period. However, the Directors of the company felt the time was right to give the shareholders the chance to decide the future direction of New Century AIM VCT 2 Plc.

The choices were:

1 To proceed with an orderly winding up of the fund and to return any monies realised to the shareholders,

2 To continue with buybacks, or

3 To continue with the fund in its present form but to focus on producing a bigger income stream for shareholders.

The Directors are pleased to report that a large number of shareholders responded to the vote and the total results received showed a majority vote of 85.71% in favour of option 3.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161202005299/en/

Copyright Business Wire 2016

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.